News About <![CDATA[Chelsea Therapeutics International Ltd.]]> News About en-us <![CDATA[Today’s Research on HSP, ALKS, CLSN, THRX, and CHTP]]> <![CDATA[Chelsea Therapeutics trims loss in 1Q]]> Chelsea Therapeutics International Ltd. reports a loss of $3.9 million, or 6 cents per share, for the first quarter. That improves on its loss of $15.6 million, or 23 cents per-share, in 2012’s first quarter. The Charlotte-based drug-development company (NASDAQ:CHTP) spent $1.9 million on research and development during the latest quarter, down from $8.6 million a year earlier. Selling, general and administrative expenses totaled $2 million, down from $6.9 million in the year-ago period. Chelsea’s…
]]>
<![CDATA[Chelsea Therapeutics International Ltd. (CHTP) Posts Q1 Loss of 6c/Share]]> <![CDATA[Chelsea Therapeutics Reports First Quarter 2013 Financial Results]]> <![CDATA[Chelsea Therapeutics to Present at the 12th Annual Needham Healthcare Conference]]> <![CDATA[Lead Counsel in Securities Class Action Against Chelsea Therapeutics International Ltd. Announces Court Hearing]]> <![CDATA[Stocks Buzz: Himax Technologies, Halcon Resources Corp, Chelsea Therapeutics International Ltd, Golden Star Resources Ltd]]> Lakeway, NY -- (SBWIRE) -- 04/17/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[NASDAQ Gainers Watch List: Athersys, Inc. (NASDAQ:ATHX), Acorda Therapeutics, Inc. (NASDAQ:ACOR), and Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) Added to Equity Profile Report's NASDAQ Gain]]> Wilmington, DE -- (SBWIRE) -- 04/17/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Athersys, Inc. (NASDAQ:ATHX), Acorda Therapeutics, Inc. (NASDAQ:ACOR), and Chelsea Therapeutics International Ltd. (NASDAQ:CHTP).

]]>
<![CDATA[Stocks Buzz: J.C. Penney Company, Inc. (NYSE:JCP), Chelsea Therapeutics International Ltd.(NASDAQ:CHTP), Globalstar, Inc.(PINK:GSAT)]]> Lakeway, NY -- (SBWIRE) -- 04/10/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and DURECT Corporation (NASDAQ:DRRX) Added to Growing Stock Report's NASDAQ Decliners Watch List.]]> New York, NY -- (SBWIRE) -- 04/10/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and DURECT Corporation (NASDAQ:DRRX).

]]>
<![CDATA[Pre-Market Analysis on Sarepta Therapeutics, BioMarin Pharma, Theravance, and Chelsea Therapeutics]]> <![CDATA[Stocks Review: Chelsea Therapeutics International Ltd, Republic Airways Holdings Inc, Santarus, Celsion Corporation]]> Lakeway, TX -- (SBWIRE) -- 04/01/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Gainers List: Darden Restaurants, Adobe Systems Incorporated, Chelsea Therapeutics International Ltd, Carnival Corporation]]> Lakeway, NY -- (SBWIRE) -- 04/01/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Investors Favorite: Newcastle Investment Corp, Chelsea Therapeutics International Ltd, Diana Shipping Inc, NVIDIA Corporation]]> Lakeway, TX -- (SBWIRE) -- 03/28/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

]]>
<![CDATA[Free Research Reports on CHTP, ECYT, MFRM and RVLT Issued by the Bedford Report ]]> <![CDATA[Stocks Showing Gaining Momentum: (NASDAQ:RVLT), (NASDAQ:CHTP)]]> <![CDATA[Chelsea Therapeutics' Northera Expected To Be Approved]]> <![CDATA[Stocks Showing Increasing Momentum: (NASDAQ: RVLT), (NASDAQ: CHTP)]]> <![CDATA[Hot Stocks: Comstock Holding Companies, Chelsea Therapeutics International, India Globalization Capital, AOL]]> Dallas, TX -- (SBWIRE) -- 03/27/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[PennyStocks101 Reports 3 TOP Stocks to Watch Closely: Nexxus Lighting, Ustarcom Holdings Corp, and Chelsea Therapeutics International]]> Beverly Hills, CA -- (SBWIRE) -- 03/27/2013 -- http://www.PennyStocks101.com - The US leader in microcap breakouts, offers a high quality stocks alert newsletter to investors looking for the best breakout stocks around. PennyStocks101 reports 3 penny stocks to keep an eye on for a possible bounce or more gains: RVLT, UTSI, and CHTP

]]>
<![CDATA[Stocks Showing Gaining Momentum: (NASDAQ:RVLT), (NASDAQ:CHTP)]]> <![CDATA[Stock to Watch: Chelsea Therapeutics International Up 10.0% (CHTP)]]> <![CDATA[Cyprus Concerns Weigh Down Markets]]> <![CDATA[NASDAQ Gainers Watch List: Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and TrovaGene, Inc. (NASDAQ:TROV) Added to Growing Stock Report's NASDAQ Gainers Watch List]]> New York, NY -- (SBWIRE) -- 03/27/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and TrovaGene, Inc. (NASDAQ:TROV).

]]>
<![CDATA[StreetInsider.com Pre-Open Movers 03/27: (UTSI) (CHTP) (MFRM) Higher; (CLF) (LNDC) (FRAN) Lower (more...)]]> <![CDATA[Chelsea Therapeutics (CHTP) Higher Following Blog Post]]> <![CDATA[Stocks to Watch: AuRico Gold Inc, Yamana Gold Inc, Barrick Gold Corporation, Chelsea Therapeutics International]]> Lakeway, NY -- (SBWIRE) -- 03/22/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Chelsea Therapeutics Announces Presentation of Northera(TM) (droxidopa) Study 306 Data at the American Academy of Neurology Annual Meeting]]> <![CDATA[US Stocks Alert: Alexion Pharmaceuticals, Chelsea Therapeutics International Ltd, Halozyme Therapeutics, Santarus]]> Lakeway, TX -- (SBWIRE) -- 03/15/2013 -- vb-news.net, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Stocks in Spotlight: Facebook Inc, Goldcorp Inc., Steel Dynamics, Chelsea Therapeutics International Ltd]]> Lakeway, TX -- (SBWIRE) -- 03/14/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Chelsea Therapeutics International and Fortress Investment Group Review: (NASDAQ: CHTP), (NYSE: FIG)]]> <![CDATA[Chelsea Therapeutics International&Fortress Investment Group Review: (NASDAQ: CHTP), (NYSE: FIG)]]> <![CDATA[Chelsea Therapeutics International&Fortress Investment Group Review: (NASDAQ: CHTP), (NYSE: FIG)]]> New York, NY -- (SBWIRE) -- 03/13/2013 -- Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) shows bullish trend as the stock made a sharp movement in its latest trading session. It opened the session at $1.95 and remained in $1.92 and $2.00 price range during the session. The stock is 2.59 percent higher at $1.98. Chelsea Therapeutics’ first support level is at $1.95. Upon breaching this level, the stock may go as low as $1.89. On the upside, its first resistance level is at $2.03.

]]>
<![CDATA[Stocks in Spotllight: Brookfield Asset Management Inc, Chelsea Therapeutics International Ltd, American Eagle Outfitters, Yum! Brands]]> Dallas, TX -- (SBWIRE) -- 03/12/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Chelsea Therapeutics to Present at the 25th Annual ROTH Conference]]> <![CDATA[Stocks Review: Cereplast Inc, Chelsea Therapeutics International Ltd, LKQ Corporation, United Continental Holdings Inc]]> Dallas, TX -- (SBWIRE) -- 03/11/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Gainers Watch List: New York Community, Key Energy Services, Chelsea Therapeutics International, Prudential Financial Inc (NYSE:PRU)]]> Lakeway, NY -- (SBWIRE) -- 03/08/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Chelsea Therapeutics International Ltd. (CHTP) Tops Q4 EPS by 5c]]> <![CDATA[Chelsea Therapeutics Reports Fourth Quarter and Full-Year 2012 Results]]> <![CDATA[BioMarin Pharma, Amgen, Sarepta Therapeutics, Chelsea Therapeutics Intl., and Theravance Early Briefing and Review]]> <![CDATA[Gainers Recap: Exelixis, Inc. (NASDAQ:EXEL), EverBank Financial Corp, Spreadtrum Communications, Chelsea Therapeutics International]]> Lakeway, NY -- (SBWIRE) -- 03/06/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Losers Recap: Seven Arts Entertainment, Chelsea Therapeutics International, Corinthian Colleges, Quicksilver Resources]]> Lakeway, NY -- (SBWIRE) -- 03/05/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Nasdaq Volume Leaders: (NASDAQ: CHTP), (NASDAQ: YHOO)]]> New York, NY -- (SBWIRE) -- 03/04/2013 -- Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) stock is at $1.6801, down 0.59 percent from its previous close of $1.69. Its latest trading volume has been recorded at 1.74 million shares, which is higher than its average daily trading volume of 1.684 million shares. The stock has made up movement with high volume and thus shows bullish trend. It is likely to go up to $1.75 level in the coming trading sessions.

]]>
<![CDATA[Nasdaq Volume Leaders: (NASDAQ: CHTP), (NASDAQ: YHOO)]]> <![CDATA[Stocks Traded Actively: Sinclair Broadcast Group, Depomed Inc, Chelsea Therapeutics International Ltd, Prana Biotechnology Limited]]> Lakeway, TX -- (SBWIRE) -- 03/04/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Biotech Stocks Alert (Arena Pharmaceuticals, Gilead Sciences, Celgene Corporation, Chelsea Therapeutics International Ltd)]]> Houston, TX -- (SBWIRE) -- 03/04/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.

]]>
<![CDATA[Investors Buzz: Chelsea Therapeutics International, Chart Industries, MBIA, Joe's Jeans]]> Lakeway, NY -- (SBWIRE) -- 03/04/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Chelsea Therapeutics & Radian Group Announcements: (NASDAQ:CHTP), (NYSE:RDN)]]> New York, NY -- (SBWIRE) -- 03/03/2013 -- Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) recently announced the receipt of guidance from the Director of the Office of New Drugs at FDA which provides Chelsea a new regulatory path forward for Northera.

]]>
<![CDATA[Chelsea Therapeutics & Radian Group Announcements: (NASDAQ: CHTP), (NYSE: RDN)]]> <![CDATA[(CHTP) Chelsea Therapeutics International Shows Encouraging News]]>
Visit StockBlogHub to view complete post.]]>